Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C12H16F3N |
| Molecular Weight | 231.2573 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN[C@H](C)CC1=CC=CC(=C1)C(F)(F)F
InChI
InChIKey=DBGIVFWFUFKIQN-SECBINFHSA-N
InChI=1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3/t9-/m1/s1
LEVOFENFLURAMINE is a levorotatory enantiomer of fenfluramine, a substituted amphetamine which was formerly used to treat obesity. LEVOFENFLURAMINE has dopamine-antagonistic properties and, at high doses, increases dopamine concentrations in rat striatal dialysates. It is essentially inactive to reduce food intake in human subjects.
CNS Activity
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Off-label promotion, on-target sales. | 2008-10-28 |
|
| Medicine as a corporate enterprise, patient welfare centered profession, or patient welfare centered professional enterprise? | 2005-11 |
|
| (+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transporters. | 2003-06 |
|
| Effects of fenfluramine and phentermine (fen-phen) on dopamine and serotonin release in rat striatum: in vivo microdialysis study in conscious animals. | 1998-11-30 |
|
| The effects of D- and L-fenfluramine (and their interactions with D-amphetamine) on psychomotor function and mood. | 1996-06 |
|
| Differential effects of d-fenfluramine, l-fenfluramine and d-amphetamine on the microstructure of human eating behaviour. | 1991-04 |
|
| Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats. | 1987-07-15 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
1670
Created by
admin on Mon Mar 31 19:23:15 GMT 2025 , Edited by admin on Mon Mar 31 19:23:15 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3616-77-1
Created by
admin on Mon Mar 31 19:23:15 GMT 2025 , Edited by admin on Mon Mar 31 19:23:15 GMT 2025
|
SUPERSEDED | |||
|
37577-24-5
Created by
admin on Mon Mar 31 19:23:15 GMT 2025 , Edited by admin on Mon Mar 31 19:23:15 GMT 2025
|
PRIMARY | |||
|
DTXSID60191009
Created by
admin on Mon Mar 31 19:23:15 GMT 2025 , Edited by admin on Mon Mar 31 19:23:15 GMT 2025
|
PRIMARY | |||
|
C175112
Created by
admin on Mon Mar 31 19:23:15 GMT 2025 , Edited by admin on Mon Mar 31 19:23:15 GMT 2025
|
PRIMARY | |||
|
521051
Created by
admin on Mon Mar 31 19:23:15 GMT 2025 , Edited by admin on Mon Mar 31 19:23:15 GMT 2025
|
PRIMARY | |||
|
SUB08470MIG
Created by
admin on Mon Mar 31 19:23:15 GMT 2025 , Edited by admin on Mon Mar 31 19:23:15 GMT 2025
|
PRIMARY | |||
|
Levofenfluramine
Created by
admin on Mon Mar 31 19:23:15 GMT 2025 , Edited by admin on Mon Mar 31 19:23:15 GMT 2025
|
PRIMARY | |||
|
6132
Created by
admin on Mon Mar 31 19:23:15 GMT 2025 , Edited by admin on Mon Mar 31 19:23:15 GMT 2025
|
PRIMARY | |||
|
953A94Y45B
Created by
admin on Mon Mar 31 19:23:15 GMT 2025 , Edited by admin on Mon Mar 31 19:23:15 GMT 2025
|
PRIMARY | |||
|
65801
Created by
admin on Mon Mar 31 19:23:15 GMT 2025 , Edited by admin on Mon Mar 31 19:23:15 GMT 2025
|
PRIMARY | |||
|
100000082295
Created by
admin on Mon Mar 31 19:23:15 GMT 2025 , Edited by admin on Mon Mar 31 19:23:15 GMT 2025
|
PRIMARY | |||
|
m5274
Created by
admin on Mon Mar 31 19:23:15 GMT 2025 , Edited by admin on Mon Mar 31 19:23:15 GMT 2025
|
PRIMARY | Merck Index | ||
|
CHEMBL438145
Created by
admin on Mon Mar 31 19:23:15 GMT 2025 , Edited by admin on Mon Mar 31 19:23:15 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)